Research Article
[Retracted] Establishment of Multiple Parameter Reference Intervals for Different Age Groups in Qingdao, China
Table 9
Reference intervals of female parameters in different age groups.
| | Groups | RIs | 18–24 (n = 120) | 25–39 (n = 120) | 40–49 (n = 120) | 50–64 (n = 120) | >65 (n = 60) |
| | FBG (mmol/L) | P2.5 | 3.93 | 3.83 | 3.99 | 4.31 | 4.32 | | P97.5 | 5.23 | 5.37 | 5.65 | 6.19 | 6.13 | | ALT (IU/L) | P2.5 | 5.00 | 6.00 | 7.00 | 8.00 | 6.00 | | P97.5 | 24.00 | 31.00 | 58.00 | 45.00 | 28.00 | | AST (IU/L) | P2.5 | 9.00 | 9.00 | 10.00 | 13.00 | 12.00 | | P97.5 | 21.00 | 26.00 | 35.00 | 28.00 | 25.00 | | BUN (mmol/L) | P2.5 | 2.62 | 2.50 | 2.56 | 3.08 | 3.72 | | P97.5 | 5.70 | 6.70 | 6.85 | 7.97 | 9.14 | | Cr (μmol/L) | P2.5 | 71.00 | 65.00 | 66.00 | 69.00 | 74.00 | | P97.5 | 98.00 | 94.00 | 102.00 | 99.00 | 102.00 | | Hb (g/L) | P2.5 | 119.0 | 115.0 | 116.0 | 120.0 | 115.0 | | P97.5 | 148.0 | 148.0 | 155.0 | 155.0 | 150.0 | | TSH (μIU/mL) | P2.5 | 0.66 | 0.82 | 0.65 | 0.58 | 0.61 | | P97.5 | 3.54 | 5.59 | 4.13 | 4.92 | 5.91 | | FT3 (pmol/L) | P2.5 | 3.66 | 3.06 | 2.78 | 3.66 | 3.39 | | P97.5 | 5.15 | 4.89 | 5.16 | 5.25 | 5.23 | | TT3 (ng/mL) | P2.5 | 0.86 | 0.74 | 0.69 | 0.86 | 0.87 | | P97.5 | 1.34 | 1.27 | 1.37 | 1.31 | 1.37 | | FT4 (pmol/L) | P2.5 | 11.92 | 10.07 | 9.67 | 11.34 | 11.19 | | P97.5 | 15.73 | 15.67 | 15.70 | 15.32 | 15.25 | | TT4 (μg/dL) | P2.5 | 6.20 | 5.73 | 5.21 | 5.75 | 5.49 | | P97.5 | 10.65 | 9.79 | 10.31 | 10.19 | 10.04 | | VB12 (pmol/L) | P2.5 | 165 | 176 | 179 | 202 | 244 | | P97.5 | 773 | 809 | 926 | 987 | 989 | | CYFRA21-1 (ng/mL) | P95 | 3.16 | 2.80 | 2.04 | 2.76 | 3.74 | | SCC (ng/mL) | P95 | 1.99 | 1.50 | 1.30 | 1.28 | 1.20 | | Anti-Tg (IU/mL) | P95 | 2.43 | 2.39 | 2.41 | 2.45 | 2.50 | | Anti-TPO (IU/mL) | P95 | 0.82 | 0.72 | 0.75 | 0.76 | 0.70 | | Ferritin (ng/mL) | P2.5 | 4.70 | 4.78 | 3.10 | 6.15 | 21.29 | | P97.5 | 98.00 | 135.50 | 140.50 | 200.11 | 225.00 |
|
|
